Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (51-60 of 460) with videos related to

Pageof 46
Sort By:
The New England Journal of Medicine|August 6, 2025
Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. ReplyJakub Svoboda, Elizabeth Hexner, Carl H June
Annual Review of Immunology|December 12, 2018
Emerging Cellular Therapies for CancerSonia Guedan, Marco Ruella, Carl H June
Cancer Cell|July 26, 2024
CAR T cell combination therapies to treat cancerUgur Uslu, Sofia Castelli, Carl H June
Cell Research|November 4, 2022
Off-the-shelf CAR T cells to treat cancerSofia Castelli, Regina M Young, Carl H June
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2017
Generating and Expanding Autologous Chimeric Antigen Receptor T Cells from Patients with Acute Myeloid LeukemiaSaad S Kenderian, Carl H June, Saar Gill
Immunity|November 17, 2016
Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to SafetyAvery D Posey, Henrik Clausen, Carl H June
Science Translational Medicine|November 9, 2022
In vivo gene immunotherapy for cancerDavid Mai, Carl H June, Neil C Sheppard
Nature Communications|July 5, 2020
Cancer immunotherapy comes of age and looks for maturityAmanda Finck, Saar I Gill, Carl H June
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2017
Studying Immunoreceptor Signaling in Human T Cells Using Electroporation of In Vitro Transcribed mRNAOmkar Kawalekar, Carl H June, Michael C Milone
Leukemia|October 14, 2018
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cellsMarion Alcantara, Melania Tesio, Carl H June, et al.
Pageof 46

Showing results (51-60 of 460) with videos related to

Sort By:
Pageof 46
The New England Journal of Medicine|August 6, 2025
Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. ReplyJakub Svoboda, Elizabeth Hexner, Carl H June
Annual Review of Immunology|December 12, 2018
Emerging Cellular Therapies for CancerSonia Guedan, Marco Ruella, Carl H June
Cancer Cell|July 26, 2024
CAR T cell combination therapies to treat cancerUgur Uslu, Sofia Castelli, Carl H June
Cell Research|November 4, 2022
Off-the-shelf CAR T cells to treat cancerSofia Castelli, Regina M Young, Carl H June
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2017
Generating and Expanding Autologous Chimeric Antigen Receptor T Cells from Patients with Acute Myeloid LeukemiaSaad S Kenderian, Carl H June, Saar Gill
Immunity|November 17, 2016
Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to SafetyAvery D Posey, Henrik Clausen, Carl H June
Science Translational Medicine|November 9, 2022
In vivo gene immunotherapy for cancerDavid Mai, Carl H June, Neil C Sheppard
Nature Communications|July 5, 2020
Cancer immunotherapy comes of age and looks for maturityAmanda Finck, Saar I Gill, Carl H June
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2017
Studying Immunoreceptor Signaling in Human T Cells Using Electroporation of In Vitro Transcribed mRNAOmkar Kawalekar, Carl H June, Michael C Milone
Leukemia|October 14, 2018
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cellsMarion Alcantara, Melania Tesio, Carl H June, et al.
Pageof 46